Why Projects Stall and how to move forward

In Life Science, planning is rarely the problem.

Organizations invest significant amounts of time in strategies, roadmaps, validation plans and regulatory assessments. Yet many projects still struggle when it’s time to move from plan to execution. Timelines slip, ownership becomes unclear, and well-designed plans fail to translate into real progress.

So why does this happen and what can be done differently?

The real challenge: Execution in a regulated reality

Life Science projects operate under unique conditions. Regulatory requirements, quality standards and patient safety must be built into every step. At the same time, organizations face increasing pressure to move faster, adopt new technologies and work cross-functionally.

Execution often breaks down when:

• Roles and responsibilities are unclear across functions
• Quality, IT, regulatory and business teams work in silos
• Plans are too theoretical and not adapted to operational reality
• Critical expertise is missing at key phases

The result is not poor compliance but slow, inefficient execution.
---------------------------------------------------------------------------------------------------------------

Five practical principles to move from planning to execution

1. Start with execution ownership, not just a project plan

A detailed plan is not enough. Every project needs clearly defined execution ownership, not only at project level, but across quality, regulatory, IT and operations.

Tip:
Define who owns decisions, who executes, and who supports early in the planning. Revisit this continuously as the project evolves.
---------------------------------------------------------------------------------------------------------------

2. Build quality and compliance into the work, not on top of it

Quality should not be something you “check at the end.” Projects move faster when QA, QA IT or Regulatory expertise are involved from the start.

Tip:
Include quality and regulatory competence already in the planning phase to avoid rework, delays and last-minute corrections.
---------------------------------------------------------------------------------------------------------------

3. Translate strategy into operational steps

Many projects fail because strategies are too abstract. Execution requires breaking ambitions down into concrete, prioritized actions.

Tip:
Ask a simple question regularly: What needs to happen for this project to move forward?
---------------------------------------------------------------------------------------------------------------

4. Use flexible expertise when and where it’s needed

Not every organisation needs all competencies in-house at all times. Interim and project-based expertise can be critical during intensive phases.

Tip:

Bring in experienced consultants who can both design and execute, especially in areas like Quality, Regulatory, Clinical, Medical Device or Pharmacovigilance.
---------------------------------------------------------------------------------------------------------------

5. Accept that plans will change and design for it

Life Science projects rarely follow a straight line. New regulatory interpretations, technical findings or organizational changes are part of reality.

Tip:
Plan for change. Build flexibility into timelines, governance and resource allocation.
---------------------------------------------------------------------------------------------------------------

Execution is where value is created

In Life Science, success is not defined by having the perfect plan but by the ability to execute consistently, compliantly and efficiently in a complex environment.

At PharmaRelations, we support organizations across the entire lifecycle, from early planning to hands-on execution, by combining deep Life Science expertise with practical, execution-ready ways of working.

The key question every organization should ask is not “Do we have a plan?”
but “Do we have the right conditions to execute it?”